BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE
申请人:Lumena Pharmaceuticals, Inc.
公开号:US20140323412A1
公开(公告)日:2014-10-30
Provided herein are methods of treating or ameliorating hypercholemia or a cholestatic liver disease by administering to an individual in need thereof a therapeutically effective amount of an Apical Sodium-dependent Bile Acid Transporter Inhibitor (ASBTI) or a pharmaceutically acceptable salt thereof. Also provided are methods for treating or ameliorating a liver disease, decreasing the levels of serum bile acids or hepatic bile acids, treating or ameliorating pruritis, reducing liver enzymes, or reducing bilirubin comprising administering to an individual in need thereof a therapeutically effective amount of ASBTI or a pharmaceutically acceptable salt thereof.
The invention relates to a dehydration process, more particularly it relates to a process for the vigorous dehydration of substances or mixtures, primarily condensation reaction mixtures, (e.g. direct esterification, direct acetal formation, direct ketal formation) using continuous azeotropic distillation with an organic solvent which forms with water a practically immiscible azeotropic mixture of minimal boiling point in such a way that the condensing distillate is cooled to at least a temperature at which the condensate with a given water content or the organic phase of the condensate is supersaturated with water, water separates and the organic phase of lower water content obtained this way is recycled back into the distillation vessel.